CIBC Bancorp USA’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$156K Buy
53,200
+26,600
+100% +$85.6K ﹤0.01% 2041
2026
Q2
$74.5K Hold
26,600
– – ﹤0.01% 1872
2026
Q1
$68.6K Buy
+26,600
New +$78.8K ﹤0.01% 1704

Other funds holding ANIX

CIBC Bancorp USA's ANIX Position: Q3 2026 in Review

CIBC Bancorp USA increased its Anixa Biosciences (ANIX) stake by 100% in Q3 2026, buying an estimated $85.6K and bringing the position to 53,200 shares worth $156K. The position accounts for ﹤0.01% of the portfolio, ranked #2041.

CIBC Bancorp USA first reported a position in ANIX in Q1 2026 and has held it in 3 quarters since. 75 funds tracked by Wall St. Rank hold ANIX as of Q3 2026.

  • CIBC Bancorp USA held 53,200 shares of Anixa Biosciences worth $156K as of Q3 2026.
  • CIBC Bancorp USA bought 26,600 Anixa Biosciences shares in Q3 2026, an estimated $85.6K.
  • Anixa Biosciences made up ﹤0.01% of CIBC Bancorp USA's portfolio in Q3 2026, its #2041 holding.
  • CIBC Bancorp USA first reported a position in Anixa Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 75 funds tracked by Wall St. Rank held Anixa Biosciences as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.